FDA-approved Alzheimer's drug lecanemab could prevent free-floating amyloid beta fibrils from damaging the brain

-
Researchers described the structure of a special type of amyloid beta plaque protein associated with Alzheimer's disease (AD) progression. Scientists showed the small aggregates of the amyloid beta protein could float through the brain tissue fluid, reaching many brain regions and disrupting local neuron functioning. The research also provided evidence that a newly approved AD treatment could neutralize these small, diffusible aggregates.
http://dlvr.it/Sp7TN4

Yorumlar

Yorum Gönder

Bu blogdaki popüler yayınlar

Reducing 'vivid imagery' that fuels addiction cravings

-
Resim
New research shows promise in treating addiction cravings by combining eye movements and guided instructions to process memories. Researchers transformed dysfunctional memories stored in the brain through processing and integration. EMDR was as effective as cognitive behavioral therapy for cravings with the combination of both resulting in more reduction in craving than cognitive behavioral therapy (CBT) alone. Both groups (experimental group and control group using only CBT) had clinically significant reductions in cravings, repetitive negative thoughts, and irrational cognitions, with the experimental group showing greater decreases overall.   http://dlvr.it/SyzZrK
Devamı

Penny for your thoughts? Master copper regulator discovery may offer Alzheimer's clues

-
Resim
A study using a tiny roundworm could pave the way for new treatments for neurodegenerative disorders. Researchers linked the worm gene swip-10 to copper regulation -- a vital element for brain health found in everyday items like wiring and cookware. Understanding the roles of swip-10 and MBLAC1, a protein involved in processing cellular materials, could lead to the development of effective medications for neurodegenerative diseases. This research opens new avenues for advancing brain disease treatments. http://dlvr.it/TDZpjl
Devamı